SC

Shubhra Chatruvedi

Active Director Director DIN 11071433
DIN 11071433 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubhra Chatruvedi

Data last updated:

Shubhra Chatruvedi is a Director at Pharmato India Private Limited (since 2025). The company operates in Pharma.

DIN 11071433
Primary Designation Director
Industry Pharma
First Appointment 23 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharmato India Private Limited U47720UP2025PTC222110
Director23 Apr 20252025Active

Board colleagues of Shubhra Chatruvedi

NameDINCompanyDesignation
Khalid Khan11071431Pharmato India Private LimitedDirector
Rahul Yadav11071432Pharmato India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmato India Private Limited
Premium access

Shareholding and investment profile for Shubhra Chatruvedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhra Chatruvedi

Shubhra Chatruvedi currently holds 1 directorship: Pharmato India Private Limited (Director, since 23 Apr 2025).

Shubhra Chatruvedi was first appointed on 23 Apr 2025 as Director at Pharmato India Private Limited.

The current boards of Shubhra Chatruvedi's companies include Khalid Khan (Pharmato India Private Limited), Rahul Yadav (Pharmato India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available